Here at STAT, we're journalists. We know well that we don't have crystal balls. But we also know that if we bring you the right voices, you'll be prepared for whatever is coming next.
We'll peer into the future of generative artificial intelligenceI in drug discovery with a top executive from Nvidia and then into other aspects of AI with a top researcher from Microsoft — before assembling a panel to really kick the tires on AI medicine with a group of experts including the chief business officer of Google Deepmind.
One of the hottest topics among STAT subscribers has been not an innovation but the realization that many scientific papers contain duplicated images or other issues of accuracy. Two of the biggest whistleblowers in this field, Elisabeth Bik and David Sholto, will join us for a conversation.
We'll leap to the event horizon where venture capital firms create new startups with a list of some picks for the most interesting among them, including Gameto, a woman-led startup focused on women's reproductive health, and Ultima Genomics, whose technology takes DNA sequencing onto silicon wafers.
We'll also take the pulse of the wearables revolution, have a look at the latest in drug discovery, and more. I promise lots of biotech. All the way through, we'll take questions and solicit opinions from an amazing, high-level audience — I just hope you'll be in it.
No comments